Patents by Inventor Klaus Lindpaintner

Klaus Lindpaintner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR CLEAR CELL RENAL CELL CARCINOMA
    Publication number: 20230112866
    Abstract: Set forth herein are methods useful for identifying disease biomarkers, particularly for diseases such as clear cell renal cell carcinoma (ccRCC). In some examples, the methods set forth herein are useful for monitoring the prognosis of patients having a disease such as ccRCC.
    Type: Application
    Filed: March 12, 2021
    Publication date: April 13, 2023
    Applicant: Venn Biosciences Corporation
    Inventors: Daniel SERIE, Klaus LINDPAINTNER
  • Impdh2 snp associated with acute rejection
    Publication number: 20100092947
    Abstract: The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a polymorphism in intron 7 of the IMPDH2 gene, optionally in combination with polymorphisms of the MDR1 and IL 10 genes which were found to be associated with this disease.
    Type: Application
    Filed: June 7, 2006
    Publication date: April 15, 2010
    Inventors: Laurent Essioux, Dorothee Foernzler, Lara Hashimoto, Klaus Lindpaintner, Michelle Rashford, Olivia Spleiss, Matt Truman, Athina Voulgari
  • IL10 SNP ASSOCIATED WITH ACUTE REJECTION
    Publication number: 20090286234
    Abstract: The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a poly-morphism in the promoter region of the IL 10 gene, optionally in combination with polymorphisms of the MDR1 and IMPDH2 genes which were found to be associated with this disease.
    Type: Application
    Filed: June 7, 2006
    Publication date: November 19, 2009
    Inventors: Laurent Essioux, Dorothee Foernzler, Lara Hashimoto, Klaus Lindpaintner, Michelle Rashford, Olivia Spleiss, Matt Truman, Athina Voulgari
  • Mdr1 Snp in Acute Rejection
    Publication number: 20090286235
    Abstract: The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a polymorphism in exon 26 of the MDR1 gene, optionally in combination with polymorphisms of the IMPDH2 and IL 10 genes which were found to be associated with this disease.
    Type: Application
    Filed: June 7, 2006
    Publication date: November 19, 2009
    Inventors: Laurent Essioux, Dorothee Foernzler, Lara Hashimoto, Klaus Lindpaintner, Michelle Rashford, Olivia Spleiss, Matt Truman, Athina Voulgari